一品红: 第四届监事会第九次会议决议公告

Group 1 - The core viewpoint of the announcement is that the Supervisory Board of Yipinhong Pharmaceutical Group Co., Ltd. has approved the transfer of minority shares from a controlling subsidiary, which aligns with the company's development strategy and complies with legal regulations [1][2] - The Supervisory Board meeting was held on May 16, 2025, with all three supervisors present, and the procedures followed legal and regulatory requirements [1] - The board unanimously agreed to use up to RMB 500 million of idle self-owned funds for cash management, focusing on safe and liquid financial products, pending approval from the shareholders' meeting [2]